Concerns about severe muscle damage from statins are largely unfounded, as new research published in The Lancet Digital Health has reaffirmed that such side effects are exceedingly rare. Statins are widely prescribed to lower LDL cholesterol and reduce the risk of heart attack and stroke, the leading causes of death globally. However, despite decades of data demonstrating their safety, many individuals remain hesitant to take the medication, often due to fears of adverse effects.
These fears contribute to underuse of statins. In the United States, less than half of the 50 million people who could benefit from statins actually use them, and up to one-third do not fill their prescriptions. Furthermore, research indicates that approximately 40% of those prescribed a statin stop taking the drug within three months.
Understanding Statin-Related Muscle Issues
The latest study, conducted by British researchers, introduced a tool designed to help clinicians better predict a patient’s risk of statin-related muscle disorders. These potential conditions include myopathy (general muscle weakness, soreness, or fatigue), myalgia (muscle pain), and rhabdomyolysis (a dangerous condition where muscle tissue rapidly breaks down, releasing toxins into the bloodstream). Rhabdomyolysis can be life-threatening.
Analyzing medical records from nearly 6 million adults in the United Kingdom, the study found that only about 0.04% of individuals had a 10-year risk of serious statin-related muscle disorders exceeding 10%. These figures are even lower than previous estimates, such as an American Heart Association report that placed the rate of myopathy below 1% and rhabdomyolysis below 0.1%.
Experts emphasize that the risk of muscular side effects is not a valid reason to avoid statins. In clinical trials, while statin users reported mild muscle pain slightly more often than placebo groups, the pain was often attributed to other causes. Dr. Steve Nissen, chief academic officer at the Cleveland Clinic’s Heart, Vascular & Thoracic Institute, stated that in his 40 years of practice, he has never admitted a patient to the hospital for a statin-associated muscle disorder.
Addressing Misinformation and Personalized Risk
The significant public concern surrounding statin side effects, despite their safety record, is often fueled by misinformation. Factors such as social media messaging, non-peer-reviewed websites, and anecdotal stories contribute to widespread fear. This contrasts with the extensive research and prescribing data available for statins, including widely used medications like atorvastatin, rosuvastatin, and simvastatin.
The new tool developed by the University of Oxford researchers aims to provide a more personalized risk assessment, moving beyond general population statistics or isolated anecdotes. By considering individual factors such as age, lifestyle, and other health conditions, clinicians can better inform patients about their specific risk profile. The researchers also emphasized the importance of distinguishing between mild, commonly reported muscle symptoms and more serious conditions like myalgia and rhabdomyolysis.
While some individuals, such as those with kidney disease or taking certain medications, may have a higher risk of side effects, and vitamin D deficiency can contribute to muscle soreness, experts stress that severe outcomes are highly unlikely. For patients experiencing any concerns after starting a statin, consulting with their doctor is crucial. Doctors can adjust dosage or discontinue the medication if necessary, as most side effects are dose-related and reversible.
Mitchell Landsberg is the senior reporter for News Raise and focuses on Technology. Mitchell regularly writes about social media platforms and how influencers, industry and general people use them to communicate and make money.
